Dr. Shanmuga Priyan Vasudevan, MD

Dr. Vasudevan practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Dr. Vasudevan's NPI, 1245670678, was assigned on June 29, 2013. Dr. Vasudevan holds Illinois license 125063503.

Dr. Vasudevan's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Dr. Vasudevan also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Dr. Vasudevan's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. Dr. Vasudevan is also affiliated with Holy Cross Hospital. The medical group on file is Sinai Medical Group. Dmand AI also links Dr. Vasudevan to 1 more hospital, 1 breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vasudevan practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Vasudevan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Vasudevan is licensed in Illinois.

CMS data shows 599 Medicare services from Dr. Vasudevan across 7 procedure codes in 2024, for 249 Medicare patients. Medicare paid $50,558 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Vasudevan in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vasudevan's median patient age at 73, with 47% women.

In 2024, Dr. Vasudevan wrote 95 Medicare Part D claims for 44 patients. 86% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $179 in total drug cost. In 2021, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Vasudevan for performance year 2024, reported as part of a group. Dr. Vasudevan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Vasudevan from 10 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $92.